Genexine Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genexine Inc with three other
companies in this sector in South Korea:
Medipost Co Ltd
sales of 37.57 billion Korean Won [US$31.90 million]
of which 64%
was Umbilical Cord Blood),
(24.84 billion Korean Won [US$21.09 million]
of which 58%
was Biotechnology), and
Seoulin Bioscience Company Limited
(41.63 billion Korean Won [US$35.34 million]
of which 97%
Genexine Inc reported sales of 32.52 billion Korean Won (US$27.61 million)
December of 2015.
increase of 95.2%
versus 2014, when the company's sales were 16.66 billion Korean Won.